+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastrointestinal Drugs Market Research Reports

Diarrhea - Pipeline Insight, 2024 - Product Thumbnail Image

Diarrhea - Pipeline Insight, 2024

  • Clinical Trials
  • May 2024
  • 80 Pages
  • Global
From
Chronic pancreatitis - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic pancreatitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Biliary Atresia - Pipeline Insight, 2024 - Product Thumbnail Image

Biliary Atresia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Erosive Esophagitis - Pipeline Insight, 2024 - Product Thumbnail Image

Erosive Esophagitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Diverticulitis - Pipeline Insight, 2024 - Product Thumbnail Image

Diverticulitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Complicated Intra-Abdominal Infections - Pipeline Insight, 2024 - Product Thumbnail Image

Complicated Intra-Abdominal Infections - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Necrotizing Enterocolitis - Pipeline Insight, 2024 - Product Thumbnail Image

Necrotizing Enterocolitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Shigellosis - Pipeline Insight, 2024 - Product Thumbnail Image

Shigellosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Stomatitis - Pipeline Insight, 2024 - Product Thumbnail Image

Stomatitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Rotavirus infections - Pipeline Insight, 2024 - Product Thumbnail Image

Rotavirus infections - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Ulcerative proctitis - Pipeline Insight, 2024 - Product Thumbnail Image

Ulcerative proctitis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Gastritis - Pipeline Insight, 2024 - Product Thumbnail Image

Gastritis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Norovirus Infection - Pipeline Insight, 2024 - Product Thumbnail Image

Norovirus Infection - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Malignant ascites - Pipeline Insight, 2024 - Product Thumbnail Image

Malignant ascites - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Constipation - Pipeline Insight, 2024 - Product Thumbnail Image

Constipation - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 90 Pages
  • Global
From
Anal Fistula - Pipeline Insight, 2024 - Product Thumbnail Image

Anal Fistula - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Abdominal Aortic Aneurysm - Pipeline Insight, 2024 - Product Thumbnail Image

Abdominal Aortic Aneurysm - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Opioid-Induced Constipation - Pipeline Insight, 2024 - Product Thumbnail Image

Opioid-Induced Constipation - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Autoimmune Gastritis - Pipeline Insight, 2024 - Product Thumbnail Image

Autoimmune Gastritis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Functional Constipation - Pipeline Insight, 2024 - Product Thumbnail Image

Functional Constipation - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists. The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more